ShadowBuys
Sign inJoin for free

Novartis AG (NVS)

Healthcare · Drug Manufacturers - General

10 members of Congress have disclosed 32 trades in Novartis AG (NVS) since 2016: 16 buys and 16 sales. The most recent was disclosed on Sep 25, 2026. 2 trades were made by members of a committee that oversees Novartis AG's industry.

Trades disclosed
32
Members trading
10
Buys / sells
16 / 16
Reported value
$285K–$1M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow NVS

What else is happening at NVS

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. NVSCompany announcement·SEC EDGAR

    NVS: 6-K company filing

    Filed 6-K for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 27, 2026, 6:08 AM EDTEvent / period: Sep 30, 2026Original source ↗
  2. NVSRegulatory notice·Federal Register

    Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Sep 17, 2026Original source ↗

Committee overlaps

Trades by members of a committee that oversees Novartis AG's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded NVS

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.